I suggest you look at the major holders of each company. How do you explain the list associated with SNSS yet there is a considerable void of institutional interest with CYCC? The lack of a legit following with CYCC would be a concern of mine as an investor. Certain contentions you make in your comparisons are credible, but as an investor, not a trader, I prefer to see a list of institutions owning a stock I am in, particularly in biotechs.
In October of last year, you said ATP Oil & Gas was a strong by at $6.00 a share. Your predictions were a little off mark.. Last I checked it was trading at $0.13 a share.
At any rate, congratulations on your two degrees in science. Next time you start a thread, maybe you could post some useful/insightful perspective? I'm curious, for example, whether or not SNSS's AML treatment might have benefit to those with MDS (Myelodysplastic syndrome), but I don't know enough about the underlying pathology to know if this is a possibility. I have no degrees in science, just an interest in putting some of my meager investment money into a company that is trying to do some good for people with terminal illnesses.